Oruka Therapeutics
- Market cap
- 5.26B
- P/E (TTM)i
- -38.97
- P/Bi
- 4.74
- EPSi
- -1.85
- Div yieldi
- 0.00%
- 52W posi
- 60%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Oruka Therapeutics closed at 79.50, down 0.85%. The company carries a market value of roughly 5.26B, the #2003 most valuable US-listed company we track. Wall Street's 11-analyst consensus lands on Buy, with a price target averaging 154.50 (+94% from here). Over the past year the stock has ranged from 24.46 to 115.52; it now sits 60% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 1% of the universe, above its 200-day average.
- Signal has read BUY for 1 week.
- Its last 3 Buy calls have averaged +7% over the following quarter.
- Recent price momentum is +140.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 80.18
- Open
- 79.01
- Day range
- 78.52 - 81.40
- Avg price
- 79.70
- Volume
- 809.90K
- Turnover
- 64.55M
- Turnover ratei
- 1.42%
- Volume ratioi
- 0.85
- Amplitudei
- 3.59%
- 52-week rangei
- 24.46 - 115.52
Valuation
- P/Ei
- -42.97
- P/E (TTM)i
- -38.97
- P/Bi
- 4.74
- EPSi
- -1.85
- Book value / shi
- 16.79
- Net profit
- -122.49M
- Net assets
- 1.11B
Share structure
- Market cap
- 5.26B
- Float capi
- 4.52B
- Shares out
- 66.21M
- Float sharesi
- 56.88M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
31.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.24M net over the window
Short interest
- Shares short
- 7.62M
- % of floati
- 11.51%
- Days to coveri
- 11.61
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Oruka Therapeutics (ORKA)?
Oruka Therapeutics last traded at 79.50. The quote on this page refreshes every few seconds while US markets are open.
What is Oruka Therapeutics's market cap?
About 5.26B.
What is the P/E ratio of Oruka Therapeutics?
The trailing twelve-month P/E is -38.97. The Valuation tab shows it against the stock's own five-year range.
Does Oruka Therapeutics pay a dividend?
Oruka Therapeutics does not currently pay a regular dividend.
Is Oruka Therapeutics a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 154.50, which implies 94.3% upside from the current price. This is not investment advice.
What is Oruka Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Oruka Therapeutics a B (Buy). Twelve-month momentum in the top 1% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:50:07 · For reference only, not investment advice and not tailored to your situation.